Updated March 28 at 10:39am
Biotechnology
42 results total, viewing 21 - 30
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
MassChallenge, a startup accelerator program, awarded $1.75 million at its annual startup awards ceremony Wednesday, the Boston Business Journal reported. more
Venture capital firm SV Life Sciences has acquired a majority interest in Ximedica from co-founders Stephen Lane and Aidan Petrie. more
The Spectranetics Corp. will acquire Covidien PLC’s Stellarex drug-coated angioplasty balloon platform for $30 million. more
Cadence Inc. celebrated the expansion of its facility with a ribbon cutting ceremony on Oct. 30. more
MedMates grew up out of a simple premise: Put enough health-tech industry members in a room together, and innovation will take care of itself. more
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
Global biotech firm Covidien PLC reported Friday that its net income rose five-tenths of a percent in its fiscal second quarter, totaling $441 million, or 97 cents per diluted share, compared with $439 million, or 92 cents per diluted share, during the same period a year earlier. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »